Artiva Biotherapeutics

Artiva Biotherapeutics is a private biotechnology company dedicated to developing off-the-shelf allogeneic NK cell therapies for the treatment of hematologic cancers or solid tumors. Artiva Biotherapeutics is built on the understanding that NK cells hold tremendous therapeutic potential as cancer therapies and is committed to overcoming the technical challenges associated with scaling and production of these cells. Artiva Biotherapeutics' mission is to deliver potent cell therapies that are also safe and immediately accessible to all cancer patients who can benefit. Artiva Biotherapeutics' platform provides scalability, quality, and cryopreservation capabilities to support a range of safe, effective, versatile, and accessible product candidates.